BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34965023)

  • 21. Two mechanisms involving the autophagic and proteasomal pathways process the metastasis suppressor protein, N-myc downstream regulated gene 1.
    Sahni S; Park KC; Kovacevic Z; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1361-1378. PubMed ID: 30763642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.
    Li A; Zhu X; Wang C; Yang S; Qiao Y; Qiao R; Zhang J
    Sci Rep; 2019 Mar; 9(1):5166. PubMed ID: 30914736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells.
    Menezes SV; Fouani L; Huang MLH; Geleta B; Maleki S; Richardson A; Richardson DR; Kovacevic Z
    Carcinogenesis; 2019 Jul; 40(6):805-818. PubMed ID: 30561520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symplekin promotes tumorigenicity by up-regulating claudin-2 expression.
    Buchert M; Papin M; Bonnans C; Darido C; Raye WS; Garambois V; Pélegrin A; Bourgaux JF; Pannequin J; Joubert D; Hollande F
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2628-33. PubMed ID: 20133805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.
    Lane DJ; Saletta F; Suryo Rahmanto Y; Kovacevic Z; Richardson DR
    PLoS One; 2013; 8(2):e57273. PubMed ID: 23437357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.
    Ai R; Sun Y; Guo Z; Wei W; Zhou L; Liu F; Hendricks DT; Xu Y; Zhao X
    Cancer Biol Ther; 2016 Sep; 17(9):943-54. PubMed ID: 27414086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.
    Xu C; Ding YH; Wang K; Hao M; Li H; Ding L
    J Transl Med; 2021 Jul; 19(1):311. PubMed ID: 34281572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of NDRG1 promotes invasion of human gastric cancer AGS cells through MMP-2.
    Liu YL; Bai WT; Luo W; Zhang DX; Yan Y; Xu ZK; Zhang FL
    Tumour Biol; 2011 Feb; 32(1):99-105. PubMed ID: 21052891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
    Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
    World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway.
    Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
    J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways.
    Kovacevic Z; Chikhani S; Lui GY; Sivagurunathan S; Richardson DR
    Antioxid Redox Signal; 2013 Mar; 18(8):874-87. PubMed ID: 22462691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR-761-mediated Ras and Rab interactor 1 signaling.
    Li C; Zhou H
    Cancer Med; 2020 Sep; 9(18):6710-6725. PubMed ID: 32706154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
    Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways.
    Ma W; Na M; Tang C; Wang H; Lin Z
    Mol Med Rep; 2015 Jul; 12(1):1050-8. PubMed ID: 25777142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway.
    Sun J; Zhang D; Zheng Y; Zhao Q; Zheng M; Kovacevic Z; Richardson DR
    Mol Pharmacol; 2013 Feb; 83(2):454-69. PubMed ID: 23188716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.
    Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T
    Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metastasis suppressor, NDRG1, differentially modulates the endoplasmic reticulum stress response.
    Merlot AM; Porter GM; Sahni S; Lim EG; Peres P; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2094-2110. PubMed ID: 30981813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
    Wu AY; Hu Y; Cang W; Li D; Wang WJ; Tian Q; Gu LY; Zhang N; Ji F; Qiu LH
    Exp Cell Res; 2019 Sep; 382(2):111468. PubMed ID: 31201812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
    Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
    Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.